SCHEMBL13738449

SCHEMBL13738449

Cc1cccc(-c2nn(C)c(-c3ccccc3)c2Cl)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.43
DPP4 P27487 1/20 0.43
NPC1 O15118 3/20 0.41
RAB9A P51151 3/20 0.41
TSHR P16473 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
HPGD P15428 2/20 0.41
ALDH1A1 P00352 3/20 0.41
NFKB1 P19838 1/20 0.41
NFKB2 Q00653 1/20 0.41
RELA Q04206 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
SLC34A1 Q06495 3/20 0.41
RXFP1 Q9HBX9 1/20 0.41
NR1H2 P55055 2/20 0.41
NR1H3 Q13133 2/20 0.41
KMT2A Q03164 2/20 0.40
NPSR1 Q6W5P4 1/20 0.40
MAPT P10636 3/20 0.40
TDP2 O95551 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13737201 0.94 RECQL (0.43) TP53NPC1RAB9ATSHRSMN1; SMN2
SCHEMBL13736647 0.85 RECQL (0.51) NPC1RAB9ASMN1; SMN2ALDH1A1NR1H2
SCHEMBL13738541 0.84 TDP1 (0.51) NPC1RAB9ASMN1; SMN2HPGDALDH1A1
SCHEMBL13736773 0.83 RECQL (0.39) NPC1RAB9ASMN1; SMN2L3MBTL1SLC34A1
SCHEMBL16200236 0.81 LMNA (0.44) TP53NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL28102140 0.78 RECQL (0.42) NPC1RAB9ASMN1; SMN2ALDH1A1NFKB1
SCHEMBL13826497 0.76 PIK3CD (0.43) NPC1RAB9ATSHRSMN1; SMN2HPGD
SCHEMBL13826210 0.76 PIK3CD (0.43) NPC1RAB9ATSHRSMN1; SMN2HPGD
SCHEMBL13736982 0.76 RECQL (0.44) NPC1RAB9ASMN1; SMN2ALDH1A1L3MBTL1
SCHEMBL13738455 0.76 MAPT (0.45) TP53SMN1; SMN2SLC34A1NR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2701510-A1 PYRAZOLOPYRIDAZINES AND METHODS FOR TREATING RETINAL-DEGENERATIVE DISEASES AND HEARING LOSS ASSOCIATED WITH USHER SYNDROME Usher III Initiative (US) 2014-03-05 EP disclosed
WO-2012148994-A1 PYRAZOLOPYRIDAZINES AND METHODS FOR TREATING RETINAL-DEGENERATIVE DISEASES AND HEARING LOSS ASSOCIATED WITH USHER SYNDROME USHER III INITIATIVE (US) 2012-11-01 WO disclosed